Le Lézard
Classified in: Health
Subjects: TDS, FDA

Quality Control Laboratory Compliance Seminar with Focus on cGMPs and GLPs (San Francisco, CA, United States - November 9-10, 2017) - Research and Markets


DUBLIN, May 26, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Quality Control Laboratory Compliance - cGMPs and GLPs: One and a Half-day In-person Seminar" conference to their offering.

Research and Markets Logo

FDA inspection and oversight of quality control (QC) laboratories are essential elements of the agency's evaluation of the compliance status of regulated companies representing multiple industries - pharmaceuticals, biologics, medical devices, as well as foods and cosmetics - as well as the contract QC laboratories which service these industries. Lack of compliance can result in severe regulatory actions, criminal liability, fines, and the inability to obtain product approvals.

This course will examine the fundamental requirements for all QC laboratories subject to FDA inspection, recent trends from FDA inspection reports and enforcement actions. In addition, this course will include a list of relevant regulations and guidelines and demonstrate how quality control and quality assurance personnel can monitor industry practices to stay current with FDA requirements (cGMPs and GLPs).

Learning Objectives:

- The basics of FDA law and regulations governing QC laboratories responsible for testing research materials, components of FDA-regulated products, and finished FDA-regulated products (pharmaceuticals, biologics, medical devices, cosmetics, and foods).
- Laboratory organization, personnel qualification and training requirements.
- Documentation and record-keeping requirements, including e-records and data integrity.
- Sample integrity requirements.
- Management and control of stability (shelf-life) studies.
- Analytical methods verification and validation.
- Management and control of laboratory instruments.
- Management and control of laboratory supplies.
- Proper conduct of laboratory investigations.
- Consequences of laboratory non-compliance.

Agenda:

Day 01 (8:30 AM - 4:30 PM)

08.30 AM - 09.00 AM: Registration

09.00 AM: Session Start

Basics of FDA law and regulations for QC laboratories

- What is adulteration?

- Pharmaceuticals
- Biologics
- Medical Devices
- Foods
- Cosmetics

- What is CGMP?

- Pharmaceuticals
- Biologics
- Medical Devices
- Foods
- Cosmetics

- What is GLP?
- What is AIP?
- Contract Laboratories
- FDA inspection methodology

Laboratory Organization

- Organization
- Personnel qualification and training

Documentation and record-keeping requirements

- Standard Operating Procedures
- Analytical Methods
- Raw data (notebooks, print-outs)
- Document management (change control, retention)
- Part 11 (electronic records and signatures)

Sample integrity requirements

- Sample collection
- Sample delivery, handling, disposition
- Retain samples

Stability (shelf-life) studies

- Organization and management
- Storage units
- Analytical methodology

Day 02 (8:30 AM - 1:00 PM)

Analytical methods verification and validation

- Protocols
- Tests
- Documentation

Management and control of laboratory instruments

- Qualification
- Calibration
- Maintenance

Management and control of laboratory supplies

- Standards
- Reagents, chemicals

Proper conduct of laboratory investigations

- Out-of-specification results
- Out-of-norm results
- Root cause analysis
- Documentation

Consequences of laboratory non-compliance
For more information about this conference visit http://www.researchandmarkets.com/research/9kswz5/quality_control

Media Contact:

Laura Wood, Senior Manager
[email protected] 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 




These press releases may also interest you

at 05:12
Swedish Orphan Biovitrum AB (publ) (Sobi®) has established a medium term note programme with a framework amount of SEK 10 billion or the equivalent thereof in EUR (the "MTN Programme"). For this purpose, Sobi has prepared a base prospectus, which...

at 04:00
OMRON Healthcare Co., Ltd. based in Muko, Kyoto Prefecture, Japan, announces to be the official sponsor of May Measurement Month (MMM,) a global campaign to raise awareness of blood pressure screening and promote hypertension prevention, detection,...

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...



News published on and distributed by: